GleamWall
中文EN

IGC IGC Pharma, Inc.

Pharmaceutical Preparations · NYSE · SEC CIK 1326205 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.9%
TTM net income YoY-25.8%
TTM EPS YoY7.4%
Revenue 3-yr CAGR-2.1%
Net income 3-yr CAGR—

Margins

Gross margin16.5%
Operating margin-802.7%
Net margin-643.7%
FCF margin-415.2%
EBITDA margin-786.5%

Returns

ROE-111.1%
ROA-83.3%
ROIC (approx.)-120.6%
Asset turnover0.13x

Leverage & solvency

Liabilities / assets33.2%
Debt / equity0.00x
Current ratio0.42x
Interest coverage-1,685.67x

Cash quality & payout

Operating cash flow / net income0.64x
Accruals ratio-29.8%
Payout ratio—
Capex / revenue1.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-03-31FY20242024-03-31
Income statement
Revenue$1.27M$1.34M
Cost of revenue$652,000$612,000
Gross profit$619,000$733,000
R&D expense$3.65M$3.77M
SG&A expense$4.41M$6.76M
Operating income-$7.45M-$9.80M
Interest expense$5,000$5,000
Pretax income-$7.12M-$13.00M
Income tax$0$0
Net income-$7.12M-$13.00M
EBITDA-$6.83M-$9.16M
EPS (basic)-0.09-0.22
EPS (diluted)-0.09-0.22
Weighted avg. shares (diluted)76.52M58.84M
Balance sheet
Cash & equivalents$405,000$1.20M
Short-term investments$0$0
Receivables$34,000$39,000
Inventory$1.36M$1.54M
Current assets$2.90M$3.71M
PP&E, net$3.22M$3.69M
Intangibles$1.85M$1.62M
Total assets$8.75M$9.90M
Current liabilities$2.26M$2.34M
Short-term debt$3,000$3,000
Long-term debt$134,000$137,000
Total debt$137,000$140,000
Total liabilities$2.42M$2.58M
Shareholders' equity$6.33M$7.32M
Net debt-$268,000-$1.06M
Shares outstanding80.88M66.69M
Cash flow statement
Operating cash flow-$4.79M-$5.20M
Capital expenditure$112,000$138,000
Free cash flow-$4.91M-$5.34M
Investing cash flow-$442,000-$317,000
Financing cash flow$4.45M$3.52M
Depreciation & amortization$618,000$637,000
Stock-based compensation$1.64M$1.77M

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.